- Friday, June 11, 2010, 0:35
- FEATURED, latest news
- 312 views
CHICAGO/NEW YORK, June 5 (Reuters) - A drug being developed by Pfizer Inc (
PFE.N) shrank lung cancer tumors in more than half of treated patients, and nearly all showed some benefit, U.S. researchers said on Saturday.
The experimental drug crizotinib is designed to target a specific genetic mutation most commonly found in nonsmokers with non-small cell lung cancer.
"Many of these patients ...
Full story
- Friday, May 21, 2010, 23:55
- FEATURED, latest news
- 804 views
20-May-2010
PRESS RELEASE
FOR IMMEDIATE RELEASE
First Self-Replicating Synthetic Bacterial Cell
First Self-Replicating, Synthetic Bacterial Cell Constructed by J. Craig Venter Institute Researchers
ROCKVILLE, MD and San Diego, CA (May 20, 2010)— Researchers at the J. Craig ...
Full story
- Friday, August 7, 2009, 16:13
- latest news
- 134 views
ondon, Aug 7 (ANI): In a study on the DNA of tiny yeast, scientists have pinpointed a large number of genes that can prevent a type of genetic rearrangement that may lead to cancer and other diseases.Many of these genes, and their accompanying pathways, are involved in repairing mistakes in DNA replication.
And the discovery of these genes by researchers at University of California, San Diego, ...
Full story
- Friday, August 7, 2009, 16:09
- latest news
- 163 views
London, Aug 7 (ANI): Small male seahorses suffer from ’short man’ syndrome, as they try to pursue the tallest females for mating, according to a study from the University of Zurich.
The research was based on the courtship rituals of the big-bellied seahorse, called Hippocampus abdominalis.
The males of the species are known to give birth, so researchers had assumed that the females were in charge when ...
Full story
- Friday, August 7, 2009, 16:03
- drugs medicine pills, latest news
- 149 views
IntelliDot System
This wireless, handheld device scans drug labels and patients' hospital wristbands to make sure patients are getting the right medicines at the right doses. (Drug errors in hospitals can be fatal.) CEO Jim Sweeney is now expanding IntelliDot into a larger hardware and software system that can ...
Full story
- Friday, August 7, 2009, 15:58
- FEATURED, latest news
- 756 views
The drug heparin is widely used to prevent blood from clotting in medical procedures ranging from dialysis to open-heart surgery. With a $6 billion market, it is one of the most common drugs used in hospitals today. But its widespread use belies its crude origins: more than 90 years after it was discovered, heparin is still made from pig intestines. But a new microfluidics chip, ...
Full story